Answers are grounded in this paper and cite their sources.
Jawbone regeneration in osteoporotic patients remains a formidable challenge due to excessive reactive oxygen species (ROS), dysregulated bone immunity, and compromised osteogenic capacity. While nanomaterial-based modulation of the bone microenvironment has emerged as a promising therapeutic strategy, most current biomaterial-based approaches target only one or two aspects of this multifaceted pathology. In this study, we developed tetrahedral DNA nanocages (TDN), which exhibit notable advantages including high biocompatibility, efficient cellular internalization, and multifaceted bioactivities that concurrently address key pathological processes in osteoporotic bone defects. Our findings demonstrate that TDN effectively scavenges intracellular ROS induced by LPS, restores mitochondrial membrane potential, and attenuates oxidative stress. Additionally, TDN promotes macrophage polarization toward the M2 phenotype and suppresses the release of pro-inflammatory cytokines by inhibiting the TNF-α/NF-κB pathway, thereby modulating immune balance. Furthermore, TDN was shown to promote the proliferation, migration, and osteogenic differentiation of bone marrow-derived mesenchymal stem cells from osteoporotic rats (OVX-BMSCs), while inhibiting their adipogenic differentiation. In vivo experiments demonstrated that TDN delivered via gelatin methacryloyl (GelMA) hydrogel scaffolds significantly enhanced regeneration in critical-sized mandibular defects in an osteoporotic model. In summary, this study reveals the multifaceted functions of TDN in alleviating oxidative stress, modulating immune homeostasis, and promoting osteogenesis within the challenging osteoporotic microenvironment, thereby offering a promising and translatable strategy for craniofacial bone regeneration in osteoporosis. This study demonstrates how tetrahedral DNA nanocages (TDN) promote osteoporotic jawbone regeneration through a multifaceted mechanism. In the pathological osteoporotic microenvironment, bone marrow mesenchymal stem cells (BMSCs) exhibit impaired osteogenesis and excessive adipogenesis, while pro-inflammatory M1 macrophages and elevated reactive oxygen species (ROS) further inhibit bone repair. Our findings reveal that TDN effectively rescue this compromised regenerative capacity by: (1) scavenging intracellular ROS and protecting mitochondrial function; (2) modulating macrophage polarization from pro-inflammatory M1 to regenerative M2 phenotypes through inhibition of the TNF-α/NF-κB signaling pathway; (3) restoring osteogenic differentiation of BMSCs while suppressing adipogenesis. These therapeutic effects were successfully translated in vivo using an injectable GelMA@TDN hydrogel scaffold, which enabled controlled TDN release and significantly enhanced bone regeneration in ovariectomized rat mandibular defects. This work establishes TDN as a promising nanotherapeutic platform that simultaneously addresses the key pathological features of osteoporotic bone defects - oxidative stress, dysregulated bone immunity and impaired osteogenesis - offering a novel strategy for degenerative craniofacial bone regeneration. • Tetrahedral DNA nanocages (TDN) restore the osteogenic-adipogenic balance of osteoporotic bone marrow stem cells by promoting their proliferation, migration, and osteogenic differentiation while suppressing adipogenic commitment. • TDN mitigate the hostile osteoporotic microenvironment through effective scavenging of reactive oxygen species (ROS) and restoration of mitochondrial function, thereby reducing oxidative stress. • TDN promote M2 macrophage polarization and inhibit inflammation via the TNF-α/NF-κB pathway, which, combined with a GelMA hydrogel delivery system, significantly enhances mandibular bone regeneration in osteoporosis.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: